, Tracking Stock Market Picks
Enter Symbol:
Rating: HOLX
Buy $41

Hologic, Inc. (NASDAQ: HOLX) upgraded to Buy with price target $41 by Needham

Thursday,  Jan 28, 2016  8:25 AM ET by Betsy O'Brien Harrison

Needham upgraded Hologic, Inc. (NASDAQ: HOLX) to Buy with price
target $41. Previously Needham upgraded to Hologic, Inc. (NASDAQ: HOLX) to Hold on 03/05/2015, when the stock price was $31.60.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy